HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
F España Selected Research
F España Research Topics
Disease
5
Endometriosis
02/2010 - 07/2003
3
Cardiovascular Diseases (Cardiovascular Disease)
01/2009 - 01/2001
3
Venous Thrombosis (Deep-Vein Thrombosis)
02/2006 - 10/2000
3
Prostatic Neoplasms (Prostate Cancer)
11/2002 - 07/2000
2
Thrombophilia
01/2016 - 12/2000
2
Thrombosis (Thrombus)
01/2016 - 12/2000
2
Venous Thromboembolism
03/2014 - 12/2001
2
Myocardial Infarction
10/2008 - 07/2006
2
Obesity
01/2007 - 08/2001
2
Coronary Artery Disease (Coronary Atherosclerosis)
07/2006 - 01/2001
2
Cysts
01/2005 - 07/2003
2
Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
11/2002 - 07/2000
1
Congenital Disorders of Glycosylation
01/2016
1
von Willebrand Diseases (von Willebrand's Disease)
11/2013
1
Hemophilia A (Haemophilia)
03/2013
1
Heart Diseases (Heart Disease)
01/2009
1
Hypertrophy
01/2009
1
Cardiac Sudden Death (Sudden Cardiac Arrest)
01/2009
1
Heart Failure
01/2009
1
Ovarian Cysts (Ovarian Cyst)
10/2007
1
Insulin Resistance
01/2007
1
Weight Loss (Weight Reduction)
08/2001
1
Inflammation (Inflammations)
06/2001
1
Necrosis
06/2001
1
Congenital Abnormalities (Deformity)
12/2000
Drug/Important Bio-Agent (IBA)
4
Proteins (Proteins, Gene)
FDA Link
03/2014 - 01/2005
4
Protein C
IBA
07/2006 - 06/2001
4
Plasminogen Activators (Plasminogen Activator)
IBA
01/2006 - 10/2000
4
Plasminogen Activator Inhibitor 1
IBA
01/2005 - 10/2000
3
Messenger RNA (mRNA)
IBA
02/2010 - 01/2005
3
Urokinase-Type Plasminogen Activator (Urokinase)
FDA Link
08/2007 - 07/2003
3
Matrix Metalloproteinases (MMPs)
IBA
08/2007 - 07/2003
2
von Willebrand Factor
IBA
11/2013 - 06/2001
2
Thrombin
FDA Link
03/2013 - 06/2001
2
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
02/2010 - 08/2007
2
Fibrinogen (Factor I)
FDA Link
01/2007 - 06/2001
2
Tissue Inhibitor of Metalloproteinase-1
IBA
01/2005 - 07/2003
2
Prostate-Specific Antigen (Semenogelase)
IBA
11/2002 - 07/2000
2
alpha 1-Antichymotrypsin (alpha 1 Antichymotrypsin)
IBA
04/2001 - 07/2000
1
Antithrombins
IBA
01/2016
1
Transferrin (beta 2 Transferrin)
IBA
01/2016
1
Glycoproteins (Glycoprotein)
IBA
01/2016
1
Endothelial Protein C Receptor
IBA
03/2014
1
Factor VIII (Coagulation Factor VIII)
IBA
03/2013
1
Biological Products
IBA
01/2009
1
Transcription Factors (Transcription Factor)
IBA
01/2009
1
MicroRNAs (MicroRNA)
IBA
01/2009
1
Interleukin-4 (Interleukin 4)
IBA
10/2008
1
Progesterone
FDA Link
Generic
10/2007
1
Metalloproteases (Metalloproteinases)
IBA
08/2007
1
Anticoagulants
IBA
07/2006
1
Finasteride (Propecia)
FDA Link
Generic
11/2002
1
Plasminogen Inactivators
IBA
08/2001
1
Lipids
IBA
08/2001
1
Trypsin
IBA
06/2001
1
Fibrinolysin
FDA Link
06/2001
1
Fibrin
IBA
06/2001
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
06/2001
1
C-Reactive Protein
IBA
06/2001
1
Cytokines
IBA
06/2001
1
Interleukin-8 (Interleukin 8)
IBA
06/2001
1
Acute-Phase Proteins (Acute-Phase Protein)
IBA
06/2001
1
Lipoprotein(a)
IBA
01/2001
1
Oral Contraceptives
IBA
12/2000
1
Prothrombin (Factor II)
IBA
12/2000
1
factor V Leiden
IBA
12/2000
Therapy/Procedure
1
Hormone Replacement Therapy (Therapy, Hormone Replacement)
01/2001
1
Transurethral Resection of Prostate (TURP)
07/2000
1
Prostatectomy (Retropubic Prostatectomy)
07/2000